Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Nicol Voermans

Showing results (11-20 of 47) with videos related to

Pageof 5
Sort By:
Neuromuscular Disorders : NMD|April 26, 2023
268th ENMC workshop - Genetic diagnosis, clinical classification, outcome measures, and biomarkers in Facioscapulohumeral Muscular Dystrophy (FSHD): Relevance for clinical trialsFederica Montagnese, Katy de Valle, Richard J L F Lemmers, et al.
Practical Neurology|July 1, 2026
Oculopharyngeal muscular dystrophy: diagnosis, management and multisystem careWesley Reintjes, Simone Knuijt, Fien Oelbrandt, et al.
Neuromuscular Disorders : NMD|November 2, 2023
Recurrent atraumatic compartment syndrome as a manifestation of genetic neuromuscular diseaseDennis T Famili, Miguel A Fernandez-Garcia, Maria Vanegas, et al.
The Cochrane Database of Systematic Reviews|December 10, 2024
Treatments for RYR1-related disordersSharika Raga, Nicol Voermans, Ivan Perez-Neri, et al.
Journal of the Neurological Sciences|July 3, 2024
An open-label pilot study of losmapimod to evaluate the safety, tolerability, and changes in biomarker and clinical outcome assessments in participants with facioscapulohumeral muscular dystrophy type 1Joost Kools, Nicol Voermans, John G Jiang, et al.
Human Molecular Genetics|January 23, 2019
Bi-allelic AEBP1 mutations in two patients with Ehlers-Danlos syndromeDelfien Syx, Inge De Wandele, Sofie Symoens, et al.
Current Pharmaceutical Design|August 5, 2021
RYR1-Related Rhabdomyolysis: A Spectrum of Hypermetabolic States Due to Ryanodine Receptor DysfunctionNick Kruijt, Luuk Van den Bersselaar, Marc Snoeck, et al.
Journal of Neuromuscular Diseases|August 2, 2021
Behavioural Impairment and Frontotemporal Dementia in Oculopharyngeal Muscular DystrophyMaurits Tankink, Corinne G C Horlings, Nicol Voermans, et al.
Journal of Neuromuscular Diseases|January 26, 2024
Facioscapulohumeral Muscular Dystrophy European Patient Survey: Assessing Patient Reported Disease Burden and Preferences in Clinical Trial ParticipationMegan M McNiff, Sheila Hawkins, Bine Haase, et al.
Mitochondrion|August 22, 2017
Two new cases of mitochondrial myopathy with exercise intolerance, hyperlactatemia and cardiomyopathy, caused by recessive SLC25A4 mutationsAnouk Tosserams, Constantinos Papadopoulos, Claude Jardel, et al.
Pageof 5

Showing results (11-20 of 47) with videos related to

Sort By:
Pageof 5
Neuromuscular Disorders : NMD|April 26, 2023
268th ENMC workshop - Genetic diagnosis, clinical classification, outcome measures, and biomarkers in Facioscapulohumeral Muscular Dystrophy (FSHD): Relevance for clinical trialsFederica Montagnese, Katy de Valle, Richard J L F Lemmers, et al.
Practical Neurology|July 1, 2026
Oculopharyngeal muscular dystrophy: diagnosis, management and multisystem careWesley Reintjes, Simone Knuijt, Fien Oelbrandt, et al.
Neuromuscular Disorders : NMD|November 2, 2023
Recurrent atraumatic compartment syndrome as a manifestation of genetic neuromuscular diseaseDennis T Famili, Miguel A Fernandez-Garcia, Maria Vanegas, et al.
The Cochrane Database of Systematic Reviews|December 10, 2024
Treatments for RYR1-related disordersSharika Raga, Nicol Voermans, Ivan Perez-Neri, et al.
Journal of the Neurological Sciences|July 3, 2024
An open-label pilot study of losmapimod to evaluate the safety, tolerability, and changes in biomarker and clinical outcome assessments in participants with facioscapulohumeral muscular dystrophy type 1Joost Kools, Nicol Voermans, John G Jiang, et al.
Human Molecular Genetics|January 23, 2019
Bi-allelic AEBP1 mutations in two patients with Ehlers-Danlos syndromeDelfien Syx, Inge De Wandele, Sofie Symoens, et al.
Current Pharmaceutical Design|August 5, 2021
RYR1-Related Rhabdomyolysis: A Spectrum of Hypermetabolic States Due to Ryanodine Receptor DysfunctionNick Kruijt, Luuk Van den Bersselaar, Marc Snoeck, et al.
Journal of Neuromuscular Diseases|August 2, 2021
Behavioural Impairment and Frontotemporal Dementia in Oculopharyngeal Muscular DystrophyMaurits Tankink, Corinne G C Horlings, Nicol Voermans, et al.
Journal of Neuromuscular Diseases|January 26, 2024
Facioscapulohumeral Muscular Dystrophy European Patient Survey: Assessing Patient Reported Disease Burden and Preferences in Clinical Trial ParticipationMegan M McNiff, Sheila Hawkins, Bine Haase, et al.
Mitochondrion|August 22, 2017
Two new cases of mitochondrial myopathy with exercise intolerance, hyperlactatemia and cardiomyopathy, caused by recessive SLC25A4 mutationsAnouk Tosserams, Constantinos Papadopoulos, Claude Jardel, et al.
Pageof 5